Specialty	Internal Medicine
Gender	Male
E-mail	steven.burakoff@mssm.edu
Education and Training	MD, Albany Medical College
	M.D., Albany Medical College
	MA (hon.), Harvard University
	MA, Queens College
	Internship and Residency, New York Hospital-Cornell Medical Center
	Fellowship, Rockefeller University
	Fellowship, Harvard Medical School
	Internship, General Medicine, Cornell Medical Center
	Residency, General Medicine, Cornell Medical Center
	Fellowship, Immunology, Rockefeller University
Awards	2009 Lifetime Achievement Award American Association of Immunologists
	2006 Lynne Cohen Foundation Awardee
	2003 Distinguished Alumnus 2003 Albany Medical College Alumni
	2002 Theobold Smith Alumni Lecture Albany Medical College
	2001 ISI Highly Cited Researcher (1980-2000)
	2000 Laura and Isaac Perlmutter Professor New York University, School of Medicine
	1998 Margaret M. Dyson Professor of Pediatrics Harvard Medical School
	1995 Association of American Physicians
	1995 Ted Williams Senior Investigator Dana-Farber Cancer Institute
	1994 Horizons in Biomedical Research Lecture Cleveland Clinic Foundation
	1992 David A. Talmadge Lecture Colorado Allergy Society

Dr. Burakoff is the Director of The Tisch Cancer Institute at Mount Sinai Medical Center; Lillian and Henry M. Stratton Professor of Cancer Medicine;  Professor of Medicine, Hematology and Medical Oncology; and Professor, Oncological Sciences.

Education and Training	MD, Albany Medical College
	M.D., Albany Medical College
	MA (hon.), Harvard University
	MA, Queens College
	Internship and Residency, New York Hospital-Cornell Medical Center
	Fellowship, Rockefeller University
	Fellowship, Harvard Medical School
	Internship, General Medicine, Cornell Medical Center
	Residency, General Medicine, Cornell Medical Center
	Fellowship, Immunology, Rockefeller University
Board Certification	Internal Medicine

Specialty	Internal Medicine
Board Certification	Internal Medicine

Major Research Interests:

   1. Cellular and molecular immunology;
   2. T cell activation and signal transduction;
   3. Transplantation immunology.

Jin YJ, Cai CY, Zhang X, Zhang HT, Burakoff SJ. Lysine144, a Ubiquitin Attachment Site in HIV-1 Nef, Is Required for Nef-mediated CD4 Downregulation. J Immunol 2008;.

Sawasdikosol S, Pyarajan S, Alzabin S, Matejovic G, Burakoff SJ. Prostaglandin E2 activates HPK1 activity via a PKA-dependent pathway. J Biol Chem 2007 Nov; 282: 34693-34699.

Mathews JP, Taylor BS, Bader GD, Pyarajan S, Antoniotti M, Chinnaiyan AM, Sander C, Burakoff SJ, Mishra B. From bytes to bedside: data integration and computational biologyfor translational cancer research. PLoS Comput Biol 2007 Feb 23; 3(2): e12.

Fragoso R, Pyarajan S, Irie HY, Burakoff SJ. CD8/Lck transgene is able to drive thymocyte differentiation. J. Immun 2006 Feb 15; 176(4): 2669.

Jin JJ, Yi Cai C, Zhang X, Zhang HT, Hirst JA, Burakoff SJ. HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. J. Immun 2006 Feb 15; 176(4): 2669.

Zambricki E, Shigeoka A, Kishimoto H, Sprent J, Burakoff S, Carpenter C, Milford E, McKay D. Signaling T cell survival and death by IL-2 and IL-15. Am J Transplant 2005; 11: 2623-2631.

Su MW, Pyarajan S, Chang JH, Yu CL, Jin YJ, Stierhof YD, Walden P, Burakoff SJ. Fratricide of CD8+ cytotoxic T Lymphocytes is dependent on cellular activation and perforin-mediated killing. Eur J Immunol 2004; 34: 2459-2470.

Frazer-Abel AA, Baksh S, Fosmire SP, Willis D, Pierce AM, Meylemans H, Linthicum DS, Burakoff SJ, Coons T, Bellgrau D. Nicotine activates NFATc2 and prevents cell cycle entry in T cells. J Pharmacol Exp Ther 2004; 311: 758-769.

Friedman JS, Alpdogan O, van den Brink MR, Liu C, Hurwiz D, Boyd A, Kupper TS, Burakoff SJ. Increasing T cell age reduces effector activity but preserves proliferative capacity in a murine allogeneic major histocompatibility complex-mismatched bone marrow transplant model. Biol Blood Marrow Transplant 2004; 10: 448-460.

Friedman JS, Lopez MF, Fleming MD, Rivera A, Martin FM, Welsh ML, Boyd AS, Doctrow SR, Burakoff SJ. SOD2 Deficiently anemia: protein oxidation and altered protein expression reveal targets of damage, stress response and anti -oxidant responsiveness. Blood 2004; 104: 2565-2573.